ASN
ADAP

Advisory Services Network’s Adaptimmune Therapeutics ADAP Stock Holding History

Advisory Services Network’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-125
Closed -$16 – 1830
2025
Q3 		$16 Buy
+125
New +$17 ﹤0.01% 4496
2024
Q1 		– Sell
-125
Closed -$99 – 1473
2023
Q4 		$99 Buy
+125
New +$70 ﹤0.01% 3778
2023
Q2 		– Sell
-325
Closed -$354 – 1454
2023
Q1 		$354 Hold
325
– – ﹤0.01% 3784
2022
Q4 		$475 Buy
+325
New +$526 ﹤0.01% 3747
2021
Q1 		– Sell
-170
Closed -$1K – 1299
2020
Q4 		$1K Hold
170
– – ﹤0.01% 3100
2020
Q3 		$1K Buy
+170
New +$1.49K ﹤0.01% 3255
2020
Q2 		– Sell
-100
Closed – – 1067
2020
Q1 		$0 Hold
100
– – ﹤0.01% 2998
2019
Q4 		$0 Hold
100
– – ﹤0.01% 3062
2019
Q3 		$0 Hold
100
– – ﹤0.01% 2792
2019
Q2 		$0 Hold
100
– – ﹤0.01% 2790
2019
Q1 		$0 Hold
100
– – ﹤0.01% 2506
2018
Q4 		$1K Sell
100
-64
-39% -$472 ﹤0.01% 2367
2018
Q3 		$2K Hold
164
– – ﹤0.01% 2281
2018
Q2 		$2K Buy
164
+64
+64% +$798 ﹤0.01% 2247
2018
Q1 		$1K Hold
100
– – ﹤0.01% 2441
2017
Q4 		$1K Hold
100
– – ﹤0.01% 2426
2017
Q3 		$1K Hold
100
– – ﹤0.01% 2247
2017
Q2 		$0 Hold
100
– – ﹤0.01% 2280
2017
Q1 		$1K Buy
+100
New +$437 ﹤0.01% 2046
2016
Q3 		$3K Buy
+400
New +$3.05K ﹤0.01% 1652

Other funds holding ADAP

JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Advisory Services Network's ADAP Position: Q4 2025 in Review

Advisory Services Network sold out of Adaptimmune Therapeutics (ADAP) in Q4 2025, closing a stake of 125 shares — an estimated $16 sold.

Advisory Services Network first reported a position in ADAP in Q3 2016 and held it in 20 quarters. The position peaked at $3K in Q3 2016. 10 funds tracked by Wall St. Rank hold ADAP as of Q4 2025.

  • Advisory Services Network reported no remaining Adaptimmune Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Advisory Services Network sold 125 Adaptimmune Therapeutics shares in Q4 2025, an estimated $16.
  • Advisory Services Network first reported a position in Adaptimmune Therapeutics in Q3 2016 and held it in 20 quarters.
  • Advisory Services Network's Adaptimmune Therapeutics position peaked at $3K in Q3 2016.
  • 10 funds tracked by Wall St. Rank held Adaptimmune Therapeutics as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.